Jupiter Neurosciences Common Stock Net 2023-2025 | JUNS

Jupiter Neurosciences common stock net from 2023 to 2025. Common stock net can be defined as the value of common equity ownership.

Jupiter Neurosciences Common Stock Net 2023-2025 | JUNS

Jupiter Neurosciences common stock net from 2023 to 2025. Common stock net can be defined as the value of common equity ownership.
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$67.5B
Zoetis (ZTS)$66B
Daiichi Sankyo, - (DSNKY)$46.3B
Takeda Pharmaceutical (TAK)$45.9B
BeOne Medicines - (ONC)$31.8B
Sandoz Group AG (SDZNY)$25.5B
Summit Therapeutics (SMMT)$21B
Merck (MKKGY)$16.3B
Shionogi (SGIOY)$15.2B
United Therapeutics (UTHR)$13.6B
Neurocrine Biosciences (NBIX)$12.3B
Orion OYJ (ORINY)$10.8B
IPSEN (IPSEY)$10.4B
Madrigal Pharmaceuticals (MDGL)$7.8B
Corcept Therapeutics (CORT)$7.6B
Grifols, S.A (GRFS)$7.3B
Stevanato Group S.p.A (STVN)$6.6B
Ionis Pharmaceuticals (IONS)$6.5B
Hikma Pharmaceuticals Plc (HKMPF)$5.3B
Ono Pharmaceutical (OPHLF)$5.1B
Soleno Therapeutics (SLNO)$4.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.8B
NewAmsterdam Pharma (NAMS)$2.7B
Hypermarcas (HYPMY)$2.7B
Crinetics Pharmaceuticals (CRNX)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.4B
Centessa Pharmaceuticals (CNTA)$2.2B
Ocular Therapeutix (OCUL)$2.2B
Endo (NDOI)$1.8B
BioCryst Pharmaceuticals (BCRX)$1.7B